3.9600
-0.0400
(-1.00%)
At close: January 29 at 3:00:00 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-17,612.0000
-17,612.0000
-24,126.0000
-35,718.0000
-18,254.0000
Investing Cash Flow
8,695.0000
8,695.0000
-7,999.0000
-30,262.0000
3,005.0000
Financing Cash Flow
4,050.0000
4,050.0000
6,417.0000
67,689.0000
58,200.0000
End Cash Position
14,556.0000
14,556.0000
19,237.0000
44,761.0000
43,154.0000
Capital Expenditure
-446.0000
-446.0000
-521.0000
-13,708.0000
--
Issuance of Capital Stock
5,094.0000
5,094.0000
7,111.0000
76,088.0000
58,334.0000
Issuance of Debt
--
--
--
--
500.0000
Repayment of Debt
-550.0000
-550.0000
-471.0000
-5,366.0000
--
Free Cash Flow
-18,058.0000
-18,058.0000
-24,647.0000
-49,426.0000
-18,254.0000
12/31/2020 - 1/8/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CYDY CytoDyn Inc.
0.2100
+1.06%
NRXP NRx Pharmaceuticals, Inc.
3.1400
-11.55%
NRXPW NRx Pharmaceuticals, Inc.
0.1900
+6.15%
ZVRA Zevra Therapeutics, Inc.
7.86
0.00%
IGXT IntelGenx Technologies Corp.
0.1700
0.00%
SRNE Sorrento Therapeutics, Inc.
0.0005
-90.00%
CELUW Celularity Inc.
0.0667
+5.37%
CELU Celularity Inc.
2.3400
-5.26%
PMN ProMIS Neurosciences, Inc.
0.8941
+1.15%
MRNS Marinus Pharmaceuticals, Inc.
0.5432
-0.15%